The Global Japanese Encephalitis Vaccines Market will Rise by almost 9% Between, 2019-2023 - ResearchAndMarkets.com

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage
Jul 12, 2019 09:03 am
DUBLIN -- 

The "Global Japanese Encephalitis Vaccines Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Global Japanese Encephalitis Vaccines Market: About this market

The inclusion of vaccination against Japanese encephalitis in national immunization plans will lead to the expansion of the global Japanese encephalitis vaccines market at a CAGR of almost 9% during the forecast period.
Japanese encephalitis is an inflammation in the brain, which is usually asymptomatic and is caused by a mosquito-borne flavivirus. This Japanese encephalitis vaccines market analysis considers sales from different type, including inactivated vaccines, recombinant vaccines, and live attenuated vaccines.
Our analysis also considers the sales of Japanese encephalitis vaccines in Asia, Europe, North America, and ROW. In 2018, the inactivated vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of choices and wide treatment options of the segment will play a significant role in the inactivated vaccines segment to maintain its market position. Also, our global Japanese encephalitis vaccines market report looks at factors such as the inclusion in national immunization plan, strategic alliances, and a growing number of awareness campaigns. However, demand-supply imbalance, geographic concentration, and weak pipeline may hamper the growth of the Japanese encephalitis vaccines industry over the forecast period.

Global Japanese Encephalitis Vaccines market: Overview

Inclusion in national immunization plan

National immunization plans to prevent the high risk of Japanese encephalitis involves mass vaccinations. This plan results in an increased procurement of vaccination doses.

Strong investments from BRICS in research

With the growing incidence of Japanese encephalitis, BRICS is developing vaccines against the indication. Pharmaceutical companies are supporting the development of these vaccines by investing in research and developmental activities. The presence of strong manufacturing facilities in BRICS countries is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global Japanese encephalitis vaccines market is concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Japanese encephalitis vaccines manufacturers, that include Bharat Biotech Ltd., Biological E. Ltd., Green Cross Corp., Sanofi, and Valneva SE.

Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Inactivated vaccines - Market size and forecast 2018-2023
  • Recombinant vaccines - Market size and forecast 2018-2023
  • Live attenuated vaccines - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Novel vaccine technology
  • Strong investments from BRICS in research
  • Growing inbound travel to Asia

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

     

For more information about this report visit https://www.researchandmarkets.com/r/nin0ti

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).
LinkedIn
StockTwits
Twitter